• Skip to main content
  • Skip to primary sidebar

Tracking Health and Wellness Applications of Brain Science

Spanish
sb-logo-with-brain
  • Resources
    • Monthly eNewsletter
    • Solving the Brain Fitness Puzzle
    • The SharpBrains Guide to Brain Fitness
    • How to evaluate brain training claims
    • Resources at a Glance
  • Brain Teasers
    • Top 25 Brain Teasers & Games for Teens and Adults
    • Brain Teasers for each Cognitive Ability
    • More Mind Teasers & Games for Adults of any Age
  • Virtual Summits
    • 2019 SharpBrains Virtual Summit
    • Speaker Roster
    • Brainnovations Pitch Contest
    • 2017 SharpBrains Virtual Summit
    • 2016 SharpBrains Virtual Summit
    • 2015 SharpBrains Virtual Summit
    • 2014 SharpBrains Virtual Summit
  • Report: Pervasive Neurotechnology
  • Report: Digital Brain Health
  • About
    • Mission & Team
    • Endorsements
    • Public Speaking
    • In the News
    • Contact Us

Akili Interactive Labs raises $160M in equity and debt to transform cognitive healthcare via prescription videogame treatments

May 26, 2021 by SharpBrains

Akili rais­es $110m to build its dig­i­tal ther­a­peu­tics pipeline (phar­mafo­rum):

Endeav­or­Rx became the first and so far only approved pre­scrip­tion video game treat­ment in the US when it was cleared by the FDA last year to treat atten­tion-deficit hyper­ac­tiv­i­ty dis­or­der (ADHD), and has also been giv­en a green light in Europe.

It is also being test­ed for oth­er indi­ca­tions includ­ing fuzzy think­ing in COVID-19 sur­vivors, a con­di­tion some­times known as ‘brain fog’.

The new fund­ing, which is accom­pa­nied by a $50 mil­lion loan facil­i­ty, is ear­marked for the con­tin­ued roll­out of the app as well as Akili’s pipeline of pre­scrip­tion dig­i­tal ther­a­peu­tics for “a range of chron­ic and acute cog­ni­tive dis­or­ders,” said the Boston-based company.

The Series D was led by Neu­berg­er Berman Funds and includ­ed a string of oth­er investors, includ­ing ven­ture cap­i­tal arms of drug­mak­ers like Shiono­gi, Amgen and Mer­ck KGaA … Oth­er pro­grammes in the R&D phase are tar­get­ing cog­ni­tive dys­func­tion in depres­sion and mul­ti­ple scle­ro­sis, autism spec­trum dis­or­der, a cog­ni­tive assess­ment tool and a gam­ing app that com­bines cog­ni­tive and phys­i­cal training.

The Announcement:

Akili Secures $160 Mil­lion in Financ­ing; Poised to Deliv­er on the Promise of Dig­i­tal Ther­a­peu­tics (press release):

… This fund­ing will sup­port a go-to mar­ket approach that brings Endeav­or­Rx to fam­i­lies and health­care pro­fes­sion­als at scale and expand Akili’s glob­al foot­print with­in atten­tion-deficit/hy­per­ac­tiv­i­ty dis­or­der (ADHD) and beyond. The financ­ing will also enable Akili to build on the suc­cess of its patent­ed tech­nol­o­gy plat­form, which has shown pos­i­tive results in clin­i­cal tri­als across a num­ber of indi­ca­tions, and fur­ther advance its pipeline of pre­scrip­tion dig­i­tal ther­a­peu­tics (PDTs) tar­get­ing a range of chron­ic and acute cog­ni­tive dis­or­ders … The financ­ing round brings the Company’s total equi­ty fund­ing to date to $230M and fur­ther posi­tions Akili to con­tin­ue lead­ing the indus­try in deliv­er­ing on the promise of bring­ing dig­i­tal ther­a­peu­tics to patients. In con­junc­tion with the Series D financ­ing, Akili also closed a cred­it facil­i­ty for up to $50M with Sil­i­con Val­ley Bank that pro­vides for an opti­mal cap­i­tal structure.

News in Context:

  • FDA clears first videogame to be pre­scribed to kids with ADHD: Endeav­or­Rx by Akili Inter­ac­tive Labs
  • Rein­vent­ing Brain Med­i­cine, Phar­ma adopts Dig­i­tal Ther­a­peu­tics: Evi­dence-based videogames, smart­phone apps, and sensors
  • Can brain train­ing work? Yes, if it meets these 5 conditions
  • What are cog­ni­tive abil­i­ties and how to boost them?

How to address pri­va­cy, eth­i­cal and reg­u­la­to­ry issues: Exam­ples in cog­ni­tive enhance­ment, depres­sion and ADHD from Sharp­Brains

Share this:

  • Tweet
  • Email
  • Print
  • More
  • Share on Tumblr
  • Pock­et

Filed Under: Attention & ADD/ADHD, Brain/ Mental Health, Technology & Innovation Tagged With: adhd, Akili, Akili Inter­ac­tive Labs, attention deficit hyperactivity disorder, cognitive healthcare, cognitive--disorders, digital therapeutics, EndeavorRx, FDA, Neuberger Berman, prescription digital therapeutics, videogame

Primary Sidebar

Top Articles on Brain Health and Neuroplasticity

  1. Can you grow your hippocampus? Yes. Here’s how, and why it matters
  2. How learning changes your brain
  3. To harness neuroplasticity, start with enthusiasm
  4. Three ways to protect your mental health during –and after– COVID-19
  5. Why you turn down the radio when you're lost
  6. Solving the Brain Fitness Puzzle Is the Key to Self-Empowered Aging
  7. Ten neu­rotech­nolo­gies about to trans­form brain enhance­ment & health
  8. Five reasons the future of brain enhancement is digital, pervasive and (hopefully) bright
  9. What Educators and Parents Should Know About Neuroplasticity and Dance
  10. The Ten Habits of Highly Effective Brains
  11. Six tips to build resilience and prevent brain-damaging stress
  12. Can brain training work? Yes, if it meets these 5 conditions
  13. What are cognitive abilities and how to boost them?
  14. Eight Tips To Remember What You Read
  15. Twenty Must-Know Facts to Harness Neuroplasticity and Improve Brain Health

Top 10 Brain Teasers and Illusions

  1. You think you know the colors? Try the Stroop Test
  2. Check out this brief attention experiment
  3. Test your stress level
  4. Guess: Are there more brain connections or leaves in the Amazon?
  5. Quick brain teasers to flex two key men­tal mus­cles
  6. Count the Fs in this sentence
  7. Can you iden­tify Apple’s logo?
  8. Ten classic optical illu­sions to trick your mind
  9. What do you see?
  10. Fun Mental Rotation challenge
  • Check our Top 25 Brain Teasers, Games and Illusions

Join 12,620 readers exploring, at no cost, the latest in neuroplasticity and brain health.

By subscribing you agree to receive our free, monthly eNewsletter. We don't rent or sell emails collected, and you may unsubscribe at any time.

IMPORTANT: Please check your inbox or spam folder in a couple minutes and confirm your subscription.

Get In Touch!

Contact Us

660 4th Street, Suite 205,
San Francisco, CA 94107 USA

About Us

SharpBrains is an independent market research firm tracking health and performance applications of brain science. We prepare general and tailored market reports, publish consumer guides, produce an annual global and virtual conference, and provide strategic advisory services.

© 2022 SharpBrains. All Rights Reserved - Privacy Policy